Here's Why TransMedics Group (TMDX) Rose in Q2

Carillon Tower Advisers' Carillon Eagle Small Cap Growth Fund Q2 2024 investor letter discusses small-cap stock performance. It highlights TransMedics Group, Inc. (NASDAQ:TMDX) as a top pick, with strong returns and revenue growth.